معرفی
Luke Davis, MD is an Associate Professor of Epidemiology (Microbial Diseases) and Medicine (Pulmonary, Critical Care & Sleep Medicine) at Yale School of Public Health, with affiliated roles at Yale Institute for Global Health and Yale Medicine. He directs the Implementation Science Track and leads international research programs focused on tuberculosis (TB) and HIV.
- Education: MD (Vanderbilt University), AB (Princeton University), MAS in Clinical Research (University of California San Francisco), Fellowship in Pulmonary & Critical Care (UCSF)
- Clinical Practice: Attending physician at Yale-New Haven Hospital's Medical ICU and Winchester TB Clinic
Research Focus: Implementation science strategies to improve TB and HIV diagnosis, treatment, and stigma reduction across Uganda, South Africa, Colombia, Mongolia, and the United States. Key projects include:
- Uganda: HIV-TB household contact investigations, gene-expression profiling for biomarker development, Xpert MTB Ultra evaluation
- Colombia: Cali TB contact investigation using design thinking
- Mongolia: Zero TB Initiative quality assessments
- Connecticut: COVID-19 contact tracing analysis
Publication Trends (15 most recent):
- 50% focus on TB-HIV coinfection and implementation trials in Sub-Saharan Africa
- 30% on digital health technologies for infectious disease management
- 20% on geriatric care innovations and medical education
Collaborations: Frequent co-authors include Sheela Shenoi, Salome Charalambous, and Donna Spiegelman. Research spans biomedical engineering integration, stigma reduction frameworks, and quality improvement methodologies.
